Novel Target in Crosshairs for Obesity and T2DM (CME/CE)

(MedPage Today) -- Natriuretic peptide dysregulation in diabetes responded to pioglitazone
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news